Beta-Sitosterol (purity>75%)
Based on 1 Customer Validation
Beta-Sitosterol (purity>75%) is a phytosterol with oral activity. Beta-Sitosterol (purity>75%) interferes with a variety of cell signaling pathways, including the cell cycle, apoptosis and cell proliferation. Beta-Sitosterol (purity>75%) has anti-inflammatory, antioxidant, and antitumor activities.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.0%
- CAS 番号: 83-46-5
- 分子式: C29H50O
- 分子量:414.71
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 1A9 | ED50 |
10.6 μg/mL
Compound: 17
|
Cytotoxicity against human 1A9 cells after 6 days by SRB assay
Cytotoxicity against human 1A9 cells after 6 days by SRB assay
|
[PMID: 14640511] |
| 1A9 | ED50 |
16.8 μg/mL
Compound: 17
|
Cytotoxicity against human 1A9 cells after 3 days by SRB assay
Cytotoxicity against human 1A9 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| 1A9/ptx-10 | ED50 |
20 μg/mL
Compound: 17
|
Cytotoxicity against human 1A9/PTX10 cells after 3 days by SRB assay
Cytotoxicity against human 1A9/PTX10 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| 1A9/ptx-10 | ED50 |
9.5 μg/mL
Compound: 17
|
Cytotoxicity against human 1A9/PTX10 cells after 6 days by SRB assay
Cytotoxicity against human 1A9/PTX10 cells after 6 days by SRB assay
|
[PMID: 14640511] |
| A2780 | IC50 |
>10 μg/mL
Compound: page 1629, R26C1
|
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| A549 | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human A549 cells after 3 days by SRB assay
Cytotoxicity against human A549 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| A549 | IC50 |
>10 μg/mL
Compound: page 1629, R26C1
|
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| Bel-7402 | IC50 |
>10 μg/mL
Compound: page 1629, R26C1
|
Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| BGC-823 | IC50 |
>10 μg/mL
Compound: page 1629, R26C1
|
Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| ECV-304 | IC50 |
472 μM
Compound: beta-sitosterol
|
Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry
Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry
|
[PMID: 22503361] |
| ECV-304 | IC50 |
472 μM
Compound: Beta-sitosterol
|
Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay
Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay
|
[PMID: 24084294] |
| ECV-304 | IC50 |
61 μM
Compound: beta-sitosterol
|
Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay
Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay
|
[PMID: 22503361] |
| ECV-304 | IC50 |
61 μM
Compound: Beta-sitosterol
|
Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay
Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay
|
[PMID: 24084294] |
| HCT-8 | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human HCT8 cells after 3 days by SRB assay
Cytotoxicity against human HCT8 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| HCT-8 | IC50 |
>10 μg/mL
Compound: page 1629, R26C1
|
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| HeLa | IC50 |
46.22 μM
Compound: 9
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 19447618] |
| HEp-2 | IC50 |
11.4 μM
Compound: 119
|
Antiproliferative activity against human Hep2 cells by MTT assay
Antiproliferative activity against human Hep2 cells by MTT assay
|
[PMID: 30830783] |
| HT-1080 | IC50 |
2.5 μM
Compound: Angelicin
|
Cytotoxicity against human HT1080 cells assessed as reduction in cell viability
Cytotoxicity against human HT1080 cells assessed as reduction in cell viability
|
[PMID: 30660827] |
| HUVEC | ED50 |
>5 μg/mL
Compound: beta-sitosterol
|
Cytotoxicity against HUVEC
Cytotoxicity against HUVEC
|
[PMID: 15043409] |
| J774 | IC50 |
>241.1 μM
Compound: 11
|
Cytotoxicity against mouse J774 cells by alamar blue assay
Cytotoxicity against mouse J774 cells by alamar blue assay
|
[PMID: 17637068] |
| KB | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human KB cells after 3 days by SRB assay
Cytotoxicity against human KB cells after 3 days by SRB assay
|
[PMID: 14640511] |
| KB | IC50 |
>10 μg/mL
Compound: 119
|
Antiproliferative activity against human KB cells assessed as reduction in cell viability
Antiproliferative activity against human KB cells assessed as reduction in cell viability
|
[PMID: 30830783] |
| KB | IC50 |
>241.5 μM
Compound: 119
|
Antiproliferative activity against human KB/HeLa cells assessed as reduction in cell viability
Antiproliferative activity against human KB/HeLa cells assessed as reduction in cell viability
|
[PMID: 30830783] |
| LNCaP | ED50 |
>5 μg/mL
Compound: beta-sitosterol
|
Cytotoxicity against human LNCAP cells
Cytotoxicity against human LNCAP cells
|
[PMID: 15043409] |
| Lu1 | ED50 |
>5 μg/mL
Compound: beta-sitosterol
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 15043409] |
| MCF7 | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human MCF7 cells after 3 days by SRB assay
Cytotoxicity against human MCF7 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| MCF7 | ED50 |
>5 μg/mL
Compound: beta-sitosterol
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 15043409] |
| MCF7 | IC50 |
42.1 μM
Compound: 9
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 19447618] |
| PC-3 | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human PC3 cells after 3 days by SRB assay
Cytotoxicity against human PC3 cells after 3 days by SRB assay
|
[PMID: 14640511] |
| SK-MEL-1 | IC50 |
>50 μM
Compound: 9
|
Cytotoxicity against human SK-MEL-1 cells by MTT assay
Cytotoxicity against human SK-MEL-1 cells by MTT assay
|
[PMID: 19447618] |
| U-87MG ATCC | ED50 |
>20 μg/mL
Compound: 17
|
Cytotoxicity against human U87MG cells after 3 days by SRB assay
Cytotoxicity against human U87MG cells after 3 days by SRB assay
|
[PMID: 14640511] |
| Vero | IC50 |
>128 μg/mL
Compound: 4
|
Cytotoxicity against african green monkey Vero cells
Cytotoxicity against african green monkey Vero cells
|
[PMID: 18818073] |
Beta-Sitosterol purity>75% (16 μM, 1, 3, 5 days) can inhibit the growth of MDA-MB-231 human breast cancer cells and induce cell apoptosis[1].
Beta-Sitosterol purity>75% (120, 240 μM, 24 h) shows significant dose-dependent growth inhibition on COLO 320 DM cells (IC50 266.2 μM). The expression of β-catenin and PCNA antigens in human colon cancer cells was inhibited by scavenging reactive oxygen species to induce cell apoptosis[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-231
-
Concentration:16 μM
-
Incubation Time:3 days
-
Result:No cytotoxicity at 16 μM
-
Cell Line:MDA-MB-231
-
Concentration:16 μM
-
Incubation Time:5 days
-
Result:Increased 33% apoptosis when assayed using 1×104 cells and a 6-fold increase in apoptosis when assayed using a smaller number of cells 5×103.
-
Cell Line:COLO 320 DM
-
Concentration:15, 30, 60, 120 μM
-
Incubation Time:24 h
-
Result:Decreased β-catenin and PCNA expression.
Beta-Sitosterol purity>75% (10, 15, 20 mg/kg, orally, for 21 consecutive days) has anti-hyperglycemic and antioxidant effects in streptozotocin (HY-13753) induced experimental hyperglycemic rat models[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Colon cancer rats model [2]
-
Dosage:10, 20 mg/kg
-
Administration:p.o., suspended in 0.1% CMC (1.0 mL)
-
Result:Reduced the number of aberrant crypt and crypt multiplicity in a dose-dependent manner.
-
Animal Model:Streptozotocin-induced hyperglycemia rats model[3]
-
Dosage:10, 15, 20 mg/kg
-
Administration:p.o.
-
Result:Increased insulin levels and decreased HbA1c levels. Improved pancreatic antioxidant levels and decreased LPO levels.
化学情報
-
CAS 番号 83-46-5
-
性状 Solid
-
分子量 414.71
-
分子式 C29H50O
-
Color White to off-white
-
SMILES
CC[C@@H](C(C)C)CC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
-
別名
β-Sitosterol (purity>75%); 22,23-Dihydrostigmasterol (purity>75%)
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMF : 16.67 mg/mL (40.20 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMF 90% Corn Oil
Solubility: ≥ 1.67 mg/mL (4.03 mM); Clear solution
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
純度とドキュメンテーション
-
データシート (277 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Awad AB, et al. Inhibition of growth and stimulation of apoptosis by beta-sitosterol treatment of MDA-MB-231 human breast cancer cells in culture. Int J Mol Med. 2000 May;5(5):541-5. [Content Brief]
[2]. Baskar AA, et al. Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study. BMC Complement Altern Med. 2010 Jun 4;10:24. [Content Brief]
[3]. Gupta R, et al. Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia. J Diabetes. 2011 Mar;3(1):29-37. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMF | 1 mM | 2.4113 mL | 12.0566 mL | 24.1132 mL | 60.2831 mL |
| 5 mM | 0.4823 mL | 2.4113 mL | 4.8226 mL | 12.0566 mL | |
| 10 mM | 0.2411 mL | 1.2057 mL | 2.4113 mL | 6.0283 mL | |
| 15 mM | 0.1608 mL | 0.8038 mL | 1.6075 mL | 4.0189 mL | |
| 20 mM | 0.1206 mL | 0.6028 mL | 1.2057 mL | 3.0142 mL | |
| 25 mM | 0.0965 mL | 0.4823 mL | 0.9645 mL | 2.4113 mL | |
| 30 mM | 0.0804 mL | 0.4019 mL | 0.8038 mL | 2.0094 mL | |
| 40 mM | 0.0603 mL | 0.3014 mL | 0.6028 mL | 1.5071 mL |